HUA MEDICINE-B (02552.HK) Stock Community - Hot Topic Discussions

Event Tracking

Dec9

Huaer Medicine Initiates HMS1005 Clinical Trial for Type 2 Diabetes in the US

11:45

Nov24

Huameng Medicine Experiences Rapid Sales Growth Post Commercialization Takeover and Pushes Development of Second-Generation GKA

03:45

Sep19

Huamedx-B Sees Significant Revenue Growth in H1 2025, Aims for Over 1 Billion Yuan in 2027

08:47

Aug28

HUA MEDICINE-B released FY2025 Q1 earnings on August 28 (BJT), actual revenue HKD 116.43 M, actual EPS HKD 0.6372

15:00

Hu Lun Pharmaceutical Reports Turnaround in Mid-Year Earnings After Bayer Agreement Termination

08:57

HUA MEDICINE-B released FY2025 Q2 earnings on August 28 Pre-Market (BJT), actual revenue HKD 118.99 M, actual EPS HKD 0.6512

01:00

Schedules & Filings

Schedules

Filings

Aug28

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 118.99 M, Net Income 647.93 M, EPS 0.6512

Mar27

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 81.51 M, Net Income -57.4 M, EPS -0.0584

Aug29

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 55.16 M, Net Income -76.42 M, EPS -0.0805

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change